MOVE OVER WARFARIN AND ASPIRIN!: NEW ANTIPLATELET AGENTS AND DIRECT ORAL ANTICOAGULANTS ADMINISTRATION IN CARDIAC SURGERY PATIENTS; BEST PRACTICES AND GUIDELINES